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The “Heavy legs” symptom is regarded as an early expression of chronic venous failure, estimated to aﬀect 40% of the population
in developing countries. A new methodology is proposed to approach the “tired or heavy legs” symptom. Seven females with
this complaint applied a standard topical formulation during 28 days in one leg randomly chosen. Local blood ﬂow records were
obtained instantaneouslyand duringpostural change with alaser doppler ﬂowmeter (LDF). High-frequency sonography and local
morphometrywerealsoobtainedatDays0,14,and28.WhencomparedwithD0,LDFvaluespresentasigniﬁcantdecreaseofboth
basal and dynamical values after Day 14 and Day 28 suggesting that this eﬀect may result from the formulation application, also
involving the related massage. Centimetric measurements and sonographic analysis also supported those inferences. The proposed
methodologycanevaluatethedynamicalchanges of “heavylegs”symptomandeventually beveryusefultoassesstherelatedclaim
support.
Copyright © 2009 P. C. Pinto and L. M. Rodrigues. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
The “tired” or “heavy” legs sensation is one of the most
frequently referred symptoms in early stages of vascular
peripheral disease. This general designation includes a wide
variety of pathologies, such as chronic venous insuﬃciency
(CVI), which seems to aﬀect up to 40% of the developed
countries population [1, 2]. This helps to justify the relevant
variety of medicinal (OTC) and health care products (cos-
metics included), mostly topical cutaneous formulations,
emerging in the last years to mitigate that condition.
Dependingontheregulatoryspace(EU,USA,orJapan)these
formulations may even be considered as borderline products
[3, 4]. In any case its eﬃcacy and claim substantiation is far
from being demonstrated, not only because the mechanisms
explaining the symptom are still partially unknown but also
because there is no directly related golden standard.
A competent venous system comprehends a superﬁcial
and a deep circulation beds connected by perforating veins.
The two circuits work together to store and return blood
to the heart [5]. A series of valves and muscle pumps helps
to keep the blood ﬂowing, preventing the backﬂow. CVI
appearswhenbloodﬂowinthevenoussystemisjeopardized,
in most cases by valvular reﬂux, thrombotic obstruction of
the valves, or both [5, 6]. In the progress of the pathology,
there is an increase of the microvascular blood ﬂow that
causes the capillaries to become dilated and tortuous [5, 7].
This increases the hydrostatic forces that lead to edema,
decreases oxygenation of the surrounding tissues, and evokes
skin changes, often stasis dermatitis [5]. In the early stages
of this evolution, subtle symptoms such as leg achiness,
heavylegs,andlegtensionsensationsareoftenpresent[5–7].
Pathophysiology suggests that “tired” or “heavy” complaints
should be related with the progressive dysfunction of periph-
eral vascular beds, involving structural, haemodynamical,
and/or functional (local related autoregulation) capacities,
although only a few papers addressed these issues [1, 2]i n
most cases by Laser Doppler Flowmetry (LDF), a widely2 Dermatology Research and Practice
known noninvasive technique. Apart from its recognized
usefulness, LDF is known to suﬀer from several method-
ological limitations [8, 9] motivating other approaches. It is
oftenassociatedtothetopicalapplicationofvasoactivedrugs
[10, 11], to local heating [12–15], and to reactive hyperemia
[16] by postural changes [17,18] or by suprasystolic pressure
cuﬀ (or even other postural maneuvers), specially focusing
the lower limb. These strategies help to reduce part of
the methodological constrains and provide a dynamical-
functional view over the vascular function [8, 16, 19, 20].
Concerning the referred topical formulations claiming
to reduce the involved discomfort, one should note that
“application” commonly involves a mechanical (massage)
eﬀect that should obviously be associated to any eventual
reduction of the symptom expression, independently from
any other therapeutical activity. But again, it would be
necessary to properly design the experimental approach to
quantitatively describe these eventual eﬀects.
This was the challenge reﬂected in the present paper, for
example, to develop a sensitive methodology contributing to
characterize the condition, eventually useful to substantiate
the so-called “tired or heavy legs” improvement claims, for
topical formulations.
2.MaterialandMethods
2.1. Subjects. Seven female volunteers (mean age: 51.7 ±
8.6y.o.) with healthy skin were selected from the database
of the Experimental Dermatology Unit and included in the
study.Allthevolunteerspresentedthe“tiredlegs”complaint,
conﬁrmed by clinical evaluation, specially the presence of
oedema, and a questionnaire. Inclusion criteria involved
nonsmoking, no vasoactive medication or product, and
restriction to drink coﬀee, tea, or any substance aﬀecting
microcirculation one day before lab evaluations. The pres-
ence of any pathology or symptom beside the “tired legs”
was the main non-inclusion criteria. Volunteers were fully
informed about the study objectives and gave their written
consent.Allproceduresadoptedwereinfullcompliancewith
the Helsinki Declaration and its subsequent amendments.
The project protocol was previously submitted and approved
by the institution’s Ethical Commission.
2.2. Formulation. An alkyl-acrylate crosspolymer gel formu-
lation with no vasoactive substances was used. This polymer
is one of the most popular component of “heavy (or tired)
legs”marketformulationsbeingallegedlyabletoimprovethe
sensation of discomfort implicit in the complaint, by a local
massage eﬀect [21].
2.3. Experimental Protocol. Volunteers were treated twice a
day for 28 days, with 2g of the formulation, applied in
one randomly chosen lower limb (foot and leg), by gentle
massage. The contralateral limb was used as a (negative)
control. The study was therefore open to the volunteers and
to the investigator. All observations and measurements were
performed at day 0 (D0), at day 14 (D14), and at the end
of the study (D28). All measurements were performed in
a controlled room (Relative Humidity <50%; Temperature
21
◦C) following a 20-minutes stabilization.
T h em i c r o c i r c u l a t i o nb l o o dﬂ o w ,e x p r e s s e di nB l o o d
Perfusion Units (BPUs) was assessed by the LDF system
Periﬂux 5010 (Perimed, Stocholm, Sweden). Measurements
were obtained after a steady local recording at rest, and
dynamically, following a postural change like the sustained
elevation of the limb from the seated position, by the same
observer. This provocation induced a local (vascular) adap-
tative response eventually modiﬁable by the test product.
High-frequency (16MHz) sonography (Dermascan C—
Cortex Technology, Denmark) was also used to complement
the analysis.
Foot and ankle (centimetric) perimeters were also regis-
tered.
2.4. Data Analysis. Statistically, the number of volunteers
chosen is supported by adequate nonparametric approach.
Descriptive statistics (MS Excel) and Wilcoxon Signed Ranks
Test (SPSS 16.0) were applied, and a conﬁdence level of 95%
adopted.
3. Results
Results presented in Table 1 show a signiﬁcant increase in the
control leg blood ﬂow, when compared with basal, after 14
and 28 days. In the treated leg, no statistical diﬀerences were
found no matter the obvious increase in the mean values. It
should be noted however that, during this period, climatic
conditions did changed, with an increase in the ambient
temperature after day 17th during the protocol execution.
Results from the absolute variation during dynamical provo-
cations are presented in Table 2. These show that in the
treated leg there are no diﬀerences regarding D0, while in the
control leg there is a variation increase, specially noted on
Day 14.
In order to minimize the inﬂuence of intrinsic and
extrinsic complicants (including the mentioned temperature
changes), data were normalized by the quotient between the
basalapplicationvalueandthecorrespondingcontrolineach
evaluation day (Figure 1).
Morfometric data were obtained by measuring the leg
and ankle perimeters at D0, D14, and D28. Variations related
to Day 0 and the corresponding statistics are summarized
in Table 3. Although not signiﬁcant, suggestive diﬀerences
are seen in the nontreated limb (leg and ankle) at D14 and
D28.
Sonographic analysis of selected oedemacious areas was
performed in a few volunteers (n = 3) to further explore
and eventually illustrate the studied eﬀects. Analysis took
place at both internal and external faces of the ankle and
included the total (cutaneous) thickness calculation. Results
from D28 were very expressive (Figures 2 and 3) conﬁrming
a clear reduction of the oedema, when compared with D0,
already detectable in D14. Additionally, in D28, volunteer’s
control leg presented an increase in the cutaneous thickness
(0,11±0,32mm)whilethetreatedleghasshownareduction
of −0.23 ±0,21mm at the same evaluation period.Dermatology Research and Practice 3
Table 1: Skin microcirculation blood ﬂow obtained during single (basal) and dynamical (Provocation, Postprovocation) measurements at
each evaluation day (∗P<. 05; NS: Nonsigniﬁcant: Comparison against D0).
BPU Treated leg Nontreated (control) leg
D0 D14 D28 D0 D14 D28
Basal 40.1+3 6 .85 5 .4+3 1 .8NS 95.65 +55.8NS 31.6+2 5 .78 7 .1+5 5 .8∗ 148.9+ 126.7∗
Provocation 64.9+4 8 .56 6 .5+3 7 .3NS 111.4+5 6 .7NS 58.3+4 2 .3 107.4+6 2 .3∗ 154.3+9 9 .5∗
Post provocation 26.7+2 9 .63 6 .3+2 0 .1NS 105.7+7 5 .9∗ 20.5+1 6 .96 0 .7+3 7 .0∗ 131.6+9 5 .6∗
Table 2: Absolute variation means during the dynamical experi-
ments.
BPU Days
D0 D14 D28
Treated 21.0+3 1 .62 2 .0+2 7 .91 8 .5+1 7 .8
Nontreated 25.3+3 5 .53 4 .5+3 7 .92 1 .6+2 4 .5
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Figure 1: Diﬀerences in each evaluation period expressed as the
variation against the control (∗P<. 05; NS: Nonsigniﬁcant:
Comparison against D0).
Table 3: Variation related to D0 of the morfometric assessment
f o re a c he v a l u a t i o na r e a( c m )( ∗P<. 05; NS: Non signiﬁcant:
Comparison against control variations).
cm Leg Ankle
Treated
D14-D0 0.07 +0.45NS 0.21+ 0.86NS
D28-D0 0.07 +0.53NS 0.35+ 0.99NS
Non-treated
D14-D0 0.29 +0.64NS 0.14+ 0.75NS
D28-D0 0.14 +0.56NS 0.21+ 0.76NS
4. Discussion
LDF is commonly used to assess local vascular conditions in
awidevarietyofpathologiesfromperipheralvasculardisease
[8] to diabetes [14, 15] or the Raynaud’s syndrome [17,
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Figure 2: Variation related to D0 of the total cutaneous thickness
for each evaluation area (mm).
18, 22]. LDF’s dynamical assessment during limb postural
changes proved to be very useful [8, 22], providing an
interesting amount of information related with the local vas-
cular function, especially regarding the veno-arterial reﬂex,
although with diﬀerent experimental approaches [8, 18, 22,
23]. In healthy subjects, a modiﬁcation of posture from lying
to standing involved an increasein the precapillaryresistance
of the foot’s skin microcirculation, leading to an increase in
local blood ﬂow [20]. When the leg is lowered from supine,
a decrease on the red cell ﬂux was described [20]. Changing
from supine to seated reportedly evoked a reduction in the
lower limb blood volume [22]. More recently, an increase of
the foot’s blood ﬂow by elevation of the leg (180
◦ regarding
the thigh) from seating was described [19]. Thus, these views
provided a practical noninvasive, functional approach to
study the impact of vasoactive substances or products on
theperipheralperfusionconditions,oﬀeringnewinsightsfor
comparative purposes.
When compared with D0, a signiﬁcant reduction of basal
LDF, in the treated area, 19% and 36% in D14 and D28,
respectively, was noted, while provocation values decreased
33% and 18% in D14 and D28. Although signiﬁcant
diﬀerences in the provocation values could not be found,
this clear tendency should be considered. This potential
eﬀect of minimizing the huge (microcirculatory) variations
evoked by the ambient temperature rising was only present4 Dermatology Research and Practice
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Figure 3: Illustrative examples of sonography images showing the
apparent reduction in the full thickness area from D0 to D28 as a
consequence of the treatment (vol#3).
in the treated limb. As shown in Table 1, LDF values in the
treated leg at D14 or D28, at rest, were similar to basal. A
totally diﬀerent condition was seen in the nontreated limb.
Dynamicalexperiencescorroboratedthoseﬁndings(Table 2)
suggesting that the intervention, involving the formulation
and the massage eﬀect, determined some protective action
that was maintained during the 28 days.
Morfometric results conﬁrmed the minimizing eﬀect of
the intervention since, in the treated limb, the diﬀerences
were clearly less evident.
Results from sonographic measurements at the selected
oedemacious areas demonstrated the oedema and skin
thickness reduction that can only be related with the
formulation application, probably involving a local blood
ﬂow improvement. In the control leg the blood ﬂow increase
was pronounced, suggesting some involvement of the veno-
arterial reﬂex which could induce or maintain the oedema
and the high skin thickness [17].
5. Conclusion
Nomatterthepresentpilot-studyapproachandtheapparent
reduced number of volunteers, this methodology did prove
to be able to characterize the vascular condition of each
individual, allowing to discriminate the eﬀects from a topical
intervention on the peripheral vascular status of the lower
limb. The proposed model may also help to look further to
the vascular failure pathophysiology.
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